Regarding the mechanism of estrogen and the carcinogenesis of lung cancer, some studies show that blocking ER can inhibit proliferation of NSCLC in mice while others have shown estrogen can reduce inflammatory cytokines which reduce the risk of NSCLC. This evidence concerns the gene ESR1 and lung cancer.